PotNetwork Holdings, Inc. Reports $18.1 Million in Sales Surpassing Entire Revenue Generated in 2017
PotNetwork Holdings, Inc. (OTC Pink: POTN ) today announced sales of $18.1 Million for the first 9 months of the year, realizing an $8.6 Million increase in year over year sales. This follows the Company’s recent announcement of its record third quarter revenues of $6.1 Million.
Driven by the growth of its wholly-owned subsidiary, Diamond CBD, Inc., PotNetwork Holdings, Inc. has taken root as an industry leader in the growing market for premium hemp extracts. PotNetwork Holdings is expanding its research and development, multinational marketing and international distribution of a broad range of hemp-derived cannabinoids and other natural hemp derivatives.
PotNetwork Holdings also reported that sales of Diamond CBD Products are coming 60% from its wholesale distribution network and 40% from online sales including from www.diamondcbd.com.
“I am extremely pleased with our year-over-year growth,” said Kevin Hagen, president of Diamond CBD. “We provide customers with a high-quality product with lab reports attached to each product displayed online. It is part of our commitment to transparency in providing the highest quality CBD to our customers.”
PotNetwork Holdings expects to file its quarterly report for the 9 months ended September 30, 2018 on or before November 14, 2018. The quarterly report will contain a further breakdown of the Company’s revenue and earnings.
About Diamond CBD, Inc. : Diamond CBD focuses on the research, development, and multinational marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.
About PotNetwork Holdings, Inc.: PotNetwork Holdings, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its principal subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD products.
Safe Harbor: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181023005241/en/
Contact information
PotNetwork Holdings, Inc.
Investor Relations:
Marisol Elwell,
1-800-915-3060
investor@PotNetworkHolding.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant Group’s AI Healthcare Manager AQ Hits 100 Million Users, Accelerating Tech Inclusion Through AI-Powered Innovations28.7.2025 15:35:00 EEST | Press release
Ant Group’s AI healthcare manager, AQ, which officially launched in June 2025, has gained 100 million users following public testing that began in September 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250728416057/en/ Ant Group launched the AI healthcare manager app AQ in June 2025. Designed to support users in managing their daily healthcare needs, AQ offers more than 100 AI-powered services, including doctor recommendations, medical report analysis, and personalized health advice. AQ also connects users to over 5,000 hospitals, nearly 1 million doctors, and 269 AI Doctor Agents co-developed with top physicians in China. This milestone marks a significant step in Ant Group’s expansion into healthcare, building on over a decade of experience supporting the digital transformation of China’s healthcare sector. “Ant Group is committed to making technology more inclusive for everyone,” said Cyril Han, CEO of Ant Group.
REPLY: The Ten Finalists of the Reply AI Film Festival Have Been Announced - the International Competition That Bridges Cinema and Artificial Intelligence28.7.2025 15:11:00 EEST | Press release
Cinema and artificial intelligence come together at the Reply AI Film Festival to explore new frontiers in storytelling and creative production. Following the success of its first edition in 2024, the international competition created by Reply – open to all creatives who have produced a short film using new technologies and AI tools – now announces its ten finalists. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250728625254/en/ The ten finalist short films were selected for their exploration of this edition's theme, 'Generation of Emotions', and for showcasing how artificial intelligence can create authentic and emotionally engaging experiences through cinematic language. The Reply AI Film Festival brings together cinema and artificial intelligence to explore new frontiers in storytelling and creative production. Following the success of its inaugural edition in 2024, the international competition, created by Reply, is ope
Filgotinib Shows Positive Topline Results Across Full Spectrum of Axial Spondyloarthritis in OLINGUITO Phase 3 Study28.7.2025 14:15:00 EEST | Press release
Alfasigma S.p.A today announced positive topline results from the OLINGUITO Phase 3 clinical trial (NCT05785611; Eudra CT 2022-501354-10-01),i evaluating filgotinib (marketed as Jyseleca® in approved indications) to treat adult patients with active axial spondyloarthritis (axSpA). Filgotinib, an oral, once-daily JAK1 preferential inhibitor, met the primary endpoint in the OLINGUITO Phase 3 clinical trial in active axSpA. Efficacy was demonstrated across the full spectrum of axSpA, including both radiographic (r-axSpA) and non-radiographic (nr-axSpA) forms. The safety profile was consistent with previous studies, with no unexpected events observed.ii Filgotinib is currently approved for the treatment of moderate to severe active rheumatoid arthritis (RA) and ulcerative colitis (UC).iii “These positive OLINGUITO topline results demonstrate filgotinib’s potential to address this critical unmet need for patients with axial spondyloarthritis, with only half responding adequately to current
Tractive Acquires Whistle from Mars Petcare to Accelerate Leadership in Global Pet Tech Market28.7.2025 14:00:00 EEST | Press release
Tractive, the global leader in GPS tracking and pet health insights, today announced it has acquired Whistle, the connected pet wearable brand owned by Mars Petcare. This strategic acquisition adds Whistle’s customer base and technology assets to Tractive, reinforcing its leadership in the fast-growing pet tech market. Founded in Austria in 2012, Tractive has established itself as the world's leading provider of smart GPS and health trackers for pets, serving over 1.4 million active users worldwide with millions of devices sold globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250728342394/en/ Whistle is now part of Tractive Whistle customers will have the option to transition to Tractive’s highly rated platform, named #1 by Consumer Reports and recognized as the top pet tracker on Amazon and top pick by The New York Times Wirecutter. The move gives Whistle users access to Tractive’s latest innovations, including rest
Deciphera Announces Positive CHMP Opinion for ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT)28.7.2025 14:00:00 EEST | Press release
Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines, andOno Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of vimseltinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250725009938/en/ The positive CHMP opinion is a scientific recommendation for marketing authorization and one of the final steps before the European Commission (EC), which has the authority to approve
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom